News About: Pharm. Industry
KFDA approves first Alzheimer's skin patch
The Korea Food and Drug Administration has approved Exelon (rivastigmine) Patch, the first skin patch for the treatment of mild to moderate Alzheimer's disease and Parkinson's disease dementia, according to Novartis K...
Yuyu to appeal Fosamax Plus case to patent court
Yuyu Pharm plans to file its lawsuit against MSD Korea to confirm the patent claims of Fosamax Plus in a patent court, after the Korean Intellectual Property Tribunal decided to reject Yuyu's claim that Fosamax Plus i...
Korea's homegrown new drug gets approval in ChinaIlyang Pharm has received marketing approval for ilaprazole, a new investigational proton pump inhibitor, from the Chinese drug regulatory agency (SFDA).
The ulcerant market ...
|
FTA will hurt pharmaceutical sector
Korea's first generic makers could lose up to 300 billion won if a U.S.-Korea free trade agreement (FTA) goes through, according to pharmaceutical business sources.
The estimated losses are based on an assumption t...
Kangwon Province beckons pharmaceutical firms seeking new investment
Investors' highlight incentives, tax breaks and a friendly atmosphere are Kangwon Province's winning points for pharmaceutical firms who seek new investment.
The province is making active efforts to expand its exis...
SK Chemicals, NCPC signs co-development of recombinant based albuminSK Chemicals said on December 13 that it has signed a contract with North China Pharmaceutical Group Corporation (NCPC), a state-owned and the largest chemic pharmaceutical ente...
|
Three drug makers to issue 'new shares'
Korea's leading pharmaceutical firms Yuhan Corporation, Hanmi Pharm and Choong-wae Pharm has decided to issue new free shares at the ratio of 0.05, 0.05 and 0.03 per share.
Yuhan, Hanmi and Choong-wae will issue ...
Drug wholesalers, GSK face off over margin
Tension is escalating between GlaxoSmithKline and Seoul based drug wholesalers over GSK's desire to slash the current wholesaler margin.
When GSK made a notice on December 10 that wholesalers should respond to GSK ...
Handok launches all-out compliance program
Handok Pharm declared on December 12 the launch of a compliance program (CP) to step up its fair trade and ethics management with the proposed opening of the company's separate website at the yearend, while publishing...
Pharmaceutical industry potential
Korea's pharmaceutical industry is emerging as a new growth engine for exports, boosted by a huge amount of investment in new GMP facilities, according to the Korea Pharmaceutical Manufacturers Association.
12 dome...
